<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION
</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>WASHINGTON, DC 20549 </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT PURSUANT </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TO SECTION 13 OR 15(D) OF THE</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Date of report (Date of earliest event
reported): <U>February 10, 2012 </U></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Bacterin International Holdings, Inc.</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="line-height: 115%; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact Name of Registrant as Specified
        in Its Charter)</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P></TD></TR>
<TR>
    <TD STYLE="line-height: 115%; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; font-size: 10pt; text-align: center">Delaware</TD></TR>
<TR>
    <TD STYLE="line-height: 115%; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">(State or Other Jurisdiction of Incorporation)</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P></TD></TR>
<TR>
    <TD STYLE="width: 1%; line-height: 115%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 50%; vertical-align: top; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; font-size: 10pt; text-align: center">001-34951</TD>
    <TD STYLE="width: 49%; vertical-align: top; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; font-size: 10pt; text-align: center">20-5313323</TD></TR>
<TR>
    <TD STYLE="line-height: 115%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; font-size: 10pt; text-align: center">(Commission File Number)</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">(IRS Employer Identification No.)</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P></TD></TR>
<TR>
    <TD STYLE="line-height: 115%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">600 Cruiser Lane</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Belgrade, Montana</P></TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; font-size: 10pt; text-align: center">59714</TD></TR>
<TR>
    <TD STYLE="line-height: 115%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; font-size: 10pt; text-align: center">(Address of Principal Executive Offices)</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">(Zip Code)</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-bottom: black 1pt solid; padding-right: -5.4pt; line-height: 115%; font-size: 10pt; text-align: center">(406) 388-0480</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">(Registrant&rsquo;s Telephone Number,
        Including Area Code)</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">(Former Name or Former Address, if Changed
        Since Last Report)</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0.3in 0 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 10.35pt; text-align: justify">Check the appropriate box below
        if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
        provisions (<U>see </U>General Instruction A.2. below):</P>
        <P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 10.35pt">&nbsp;<FONT STYLE="font-family: Wingdings 2">&pound;</FONT><FONT STYLE="font-size: 10pt; color: black">
        Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></P>
        <P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 10.35pt">&nbsp;<FONT STYLE="font-family: Wingdings 2">&pound;</FONT><FONT STYLE="font-size: 10pt; color: black">
        Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></P>
        <P STYLE="font: 10pt/12pt Times New Roman, Times, Serif; margin: 0 0 10.35pt">&nbsp;<FONT STYLE="font-family: Wingdings 2">&pound;</FONT><FONT STYLE="font-size: 10pt; color: black">
        Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;<FONT STYLE="font-family: Wingdings 2">&pound;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; color: black">
        Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><B>Item 7.01&#9;Regulation FD Disclosure.</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 1.8pt 10pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company has issued a press release entitled &ldquo;Bacterin Study at AAOS 2012 Annual Meeting Shows OsteoSponge</FONT><FONT STYLE="font-size: 12pt; line-height: 115%">&reg;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
Equivalence to rhBMP-2 in Spinal Fusion; Presented Specifically to Orthopaedic Surgeons&rdquo; which is attached as Exhibit 99.1
and incorporated herein. </FONT></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 1.8pt 10pt 0; text-align: justify">The information in this Item
7.01 and the document attached as Exhibit 99.1 are being furnished and shall not be deemed &ldquo;filed&rdquo; for purposes of
Section 18 of the Securities and Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), nor otherwise subject to the
liabilities of that section, nor incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act,
except as shall be expressly set forth by specific reference in such a filing. <FONT STYLE="font-size: 10pt; line-height: 115%">
</FONT></P>

<TABLE ALIGN="CENTER" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-family: Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 78px">&nbsp;</TD>
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Item 9.01.</B> &nbsp;&#9;<B>Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(d)&nbsp;&nbsp;<U>Exhibits</U>.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 11%; vertical-align: top; border-bottom: black 1.5pt solid; line-height: 115%; font-size: 10pt; font-weight: bold">Exhibit No</TD>
    <TD STYLE="width: 2%; line-height: 115%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 87%; vertical-align: top; border-bottom: black 1.5pt solid; line-height: 115%; font-size: 10pt; font-weight: bold">Description</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; line-height: 115%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="line-height: 115%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-size: 10pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">99.1</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD>
    <TD STYLE="line-height: 115%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Press Release of Bacterin International Holdings, Inc. dated February 10, 2012 entitled &ldquo;Bacterin Study at AAOS 2012 Annual Meeting Shows OsteoSponge</FONT><FONT STYLE="font-size: 12pt">&reg;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"> Equivalence to rhBMP-2 in Spinal Fusion; Presented Specifically to Orthopaedic Surgeons&rdquo;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; line-height: 115%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="line-height: 115%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; line-height: 115%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="line-height: 115%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">SIGNATURE</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; font-size: 10pt; text-align: justify">Dated:&nbsp; February 10, 2012</TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; font-size: 10pt; text-align: justify"><B>BACTERIN INTERNATIONAL HOLDINGS, INC</B>.</TD></TR>
<TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; font-size: 10pt; text-decoration: underline; text-align: justify">By:&nbsp; /s/ Guy S. Cook</TD></TR>
<TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; font-size: 10pt; text-align: justify">Name:&nbsp; Guy S. Cook</TD></TR>
<TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; font-size: 10pt; text-align: justify">Title: President and Chief Executive Officer<U> </U></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 11%; vertical-align: top">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">99.1</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD>
    <TD STYLE="width: 1%; line-height: 115%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 88%; vertical-align: top; line-height: 115%; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Press Release of Bacterin International Holdings, Inc. dated February 10, 2012 entitled &ldquo;Bacterin Study at AAOS 2012 Annual Meeting Shows OsteoSponge</FONT><FONT STYLE="font-size: 12pt">&reg;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"> Equivalence to rhBMP-2 in Spinal Fusion; Presented Specifically to Orthopaedic Surgeons&rdquo;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>



<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v302156_8-k.htm", "description": "8-K", "secsgml_size_bytes": 18340}]
{"company-data": {"conformed-name": "Bacterin International Holdings, Inc.", "cik": "0001453593", "assigned-sic": "2836", "irs-number": "205313323", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-34951", "film-number": "12594342"}, "business-address": {"street1": "600 CRUISER LANE", "city": "BELGRADE", "state": "MT", "zip": "59714", "phone": "406-388-0480"}, "mail-address": {"street1": "600 CRUISER LANE", "city": "BELGRADE", "state": "MT", "zip": "59714"}, "former-company": {"former-conformed-name": "K KITZ INC", "date-changed": "20090108"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event
reported):
February 10, 2012
Bacterin International Holdings, Inc.
(Exact Name of Registrant as Specified
        in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
001-34951
20-5313323
(Commission File Number)
(IRS Employer Identification No.)
600 Cruiser Lane
Belgrade, Montana
59714
(Address of Principal Executive Offices)
(Zip Code)
(406) 388-0480
(Registrant's Telephone Number,
        Including Area Code)
(Former Name or Former Address, if Changed
        Since Last Report)
Check the appropriate box below
        if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
        provisions (
see
General Instruction A.2. below):
£
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
£
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01	Regulation FD Disclosure.
The
Company has issued a press release entitled "Bacterin Study at AAOS 2012 Annual Meeting Shows OsteoSponge
®
Equivalence to rhBMP-2 in Spinal Fusion; Presented Specifically to Orthopaedic Surgeons" which is attached as Exhibit 99.1
and incorporated herein.
The information in this Item
7.01 and the document attached as Exhibit 99.1 are being furnished and shall not be deemed "filed" for purposes of
Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), nor otherwise subject to the
liabilities of that section, nor incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act,
except as shall be expressly set forth by specific reference in such a filing.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits
.
Exhibit No
Description
99.1
Press Release of Bacterin International Holdings, Inc. dated February 10, 2012 entitled "Bacterin Study at AAOS 2012 Annual Meeting Shows OsteoSponge
®
Equivalence to rhBMP-2 in Spinal Fusion; Presented Specifically to Orthopaedic Surgeons"
SIGNATURE
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated:  February 10, 2012
BACTERIN INTERNATIONAL HOLDINGS, INC
.
By:  /s/ Guy S. Cook
Name:  Guy S. Cook
Title: President and Chief Executive Officer
EXHIBIT INDEX
99.1
Press Release of Bacterin International Holdings, Inc. dated February 10, 2012 entitled "Bacterin Study at AAOS 2012 Annual Meeting Shows OsteoSponge
®
Equivalence to rhBMP-2 in Spinal Fusion; Presented Specifically to Orthopaedic Surgeons"